These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


159 related items for PubMed ID: 7846723

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [The therapy of inflammatory diseases of the maxillofacial area with the use of imidazole derivatives].
    Ushakov RV, Tsarev VN, Dugarov BD, Lopyrev VA.
    Stomatologiia (Mosk); 1992; (3-6):31-4. PubMed ID: 1307150
    [Abstract] [Full Text] [Related]

  • 4. [New antimicrobial preparations in the overall treatment of suppurative inflammatory processes in the maxillofacial area].
    Solomennyĭ SM, Paliĭ GK, Burdeniuk IP.
    Stomatologiia (Mosk); 1979; 58(2):39-41. PubMed ID: 375477
    [No Abstract] [Full Text] [Related]

  • 5. [Use of a chloracetophos ointment in the combined treatment of acute odontogenic inflammatory processes of the maxillofacial area].
    Khamitov FS, Faizov TT, Berim MG.
    Stomatologiia (Mosk); 1985; 64(1):35-7. PubMed ID: 3857735
    [No Abstract] [Full Text] [Related]

  • 6. [Treatment of patients with phlegmon of the maxillofacial area using a levomecol ointment].
    Chernoglazova EM.
    Stomatologiia (Mosk); 1987; 66(5):42-4. PubMed ID: 3480633
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [The use of alginic acid-based preparations for treating suppurative wounds of the maxillofacial area and neck].
    Ushakov RV, Dugarov BD, Iakubovich VS, Komissarova AL, Shargorodskiĭ VM.
    Stomatologiia (Mosk); 1991; (5):46-7. PubMed ID: 1724711
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Experience with the treatment of children with suppurative inflammatory processes in the maxillofacial region].
    Chmyrev VS.
    Stomatologiia (Mosk); 1974; 53(4):49-51. PubMed ID: 4529134
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Use of proteolytic enzymes in the treatment of acute suppurative diseases of the maxillo-facial area].
    Protasevich AI.
    Vestn Khir Im I I Grek; 1969 Mar; 102(3):83-5. PubMed ID: 5358819
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Means of decreasing complications in patients with severe inflammatory diseases of the maxillofacial area].
    Zakharova GN, Bulkin VA.
    Stomatologiia (Mosk); 1987 Mar; 66(3):37-9. PubMed ID: 3475830
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [The clinico-laboratory assessment of the efficacy of dalargin in treating acute suppurative-inflammatory processes of the maxillofacial area].
    Bazhanov NN, Ganina SS, Pashutin SB, Ragimov ChR.
    Sov Med; 1991 Mar; (7):29-31. PubMed ID: 1948337
    [Abstract] [Full Text] [Related]

  • 19. [Regional lymphotropic antibiotic therapy as a part of comprehensive treatment of children with purulent-inflammatory diseases of maxillofacial region].
    Zhanalina BS.
    Stomatologiia (Mosk); 2008 Mar; 87(2):70-2. PubMed ID: 18454123
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.